- Home
- SPRY vs PRCH Comparison
SPRY vs PRCH Comparison
Compare SPRY & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPRY | PRCH |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.2M | 1.1B |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SPRY | PRCH |
|---|---|---|
| Price | $7.35 | $9.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $40.00 | $18.63 |
| AVG Volume (30 Days) | 1.8M | ★ 2.3M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.91 |
| EPS | N/A | ★ N/A |
| Revenue | $84,278,000.00 | ★ $482,414,000.00 |
| Revenue This Year | $87.40 | $4.15 |
| Revenue Next Year | $81.64 | $17.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.18 |
| 52 Week Low | $6.66 | $6.36 |
| 52 Week High | $18.63 | $19.44 |
Technical Indicators
Market Signals| Indicator | SPRY | PRCH |
|---|---|---|
| Relative Strength Index (RSI) | 33.68 | 55.57 |
| Support Level | $6.66 | $8.93 |
| Resistance Level | $8.61 | $11.19 |
| Average True Range (ATR) | 0.52 | 0.75 |
| MACD | -0.14 | -0.10 |
| Stochastic Oscillator | 9.45 | 38.08 |
Price Performance
Historical ComparisonAbout SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has four reportable segments: Insurance Services, Software & Data, Consumer Services, and Corporate. The majority of revenue is from the Insurance segment. The Insurance Services segment manages and operates the Reciprocal, providing services related, but not limited, to underwriting, policy renewal, risk management, insurance portfolio management, financial management, and setting investment guidelines in exchange for commissions and fees.